Genome Sequencing Azenta Life Sciences Expands Fleet of Pacbio Hifi Sequencing Systems
Pacbio announced an expansion of its extensive suite of Hifi applications with Azenta Life Sciences, formerly Genewiz.
A deal signed with Azenta Life Sciences is to increase Pacbio’s Hifi sequencing platforms across Azenta’s newly combined company. The Hifi sequencing technology uniquely combines the benefits of high accuracy with long read lengths, providing a comprehensive view of genomes and transcriptomes to scientists tackling complex genetic challenges. Azenta’s expanded investment in Hifi sequencing signifies the technology’s ability to unlock insights for researchers in academia, pharma, and biotech.
“Azenta is a global leader in genomics services, and we’re very pleased that our highly accurate Hifi sequencing technology will continue to underpin leading-edge research to build a healthier world for people everywhere,” said Christian Henry, CEO at Pacbio.
With more than 20 years of experience specializing in DNA and RNA sequencing and synthesis services, working with over 6000 institutions worldwide, Azenta is using Pacbio Sequel IIe technology to offer enterprise-wide sample exploration and management solutions across the drug development pipeline.